Launch week offerEnds in00h00m00s

annual Promonthly Pro

Luca Licata

Ospedale San Raffaele

Italy

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Articles (11)

Year:

2026

Year:

2026

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (9)

Fabio Puglisi

Head of the Unit of Medical Oncology and Cancer Prevention

ITALY

View details

Lajos Pusztai

Yale University

UNITED STATES

View details

Christos Sotiriou

Université libre de Bruxelles

BELGIUM

View details

Lucia Del Mastro

dirigente medico

IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro

ITALY

View details

Kevin Kalinsky

Emory University

UNITED STATES

View details

Thomas Karn

Goethe University Frankfurt

GERMANY

View details

Elisabetta Munzone

Director

European Institute of Oncology

ITALY

View details

Federica Giugliano

Institut Gustave Roussy

FRANCE

View details

Giampaolo Bianchini

Head Breast Cancer Group

IRCCS Ospedale San Raffaele

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Luca Licata

Research Interests

Make your next move.

Explore related searches

Articles (11)

Navigating uncertainties and evidence gaps in adjuvant therapy for premenopausal women with HR+/HER2- breast cancer

Low Rates of Discontinuation Unrelated to Disease Progression with Trastuzumab Deruxtecan in Metastatic Breast Cancer: A Real-World Study

Timing of Recurrence after Neoadjuvant Chemo-Immunotherapy in Patients with Early-Stage Triple-Negative Breast Cancer

PARP Inhibitors for Breast Cancer Treatment

Navigating practical challenges in immunotherapy for metastatic triple negative breast cancer

Real-world use of multigene signatures in early breast cancer: differences to clinical trials

Breast cancers with high proliferation and low ER-related signalling have poor prognosis and unique molecular features with implications for therapy

Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancer

Multigene signatures for early breast cancer in clinical practice: A report of the Lombardy genomic assays for breast cancer working group

Pan-cancer analysis of antibody-drug conjugate targets and putative predictors of treatment response

Tissue- and liquid biopsy-based biomarkers for immunotherapy in breast cancer

Collaborators (9)

Fabio Puglisi

Lajos Pusztai

Christos Sotiriou

Lucia Del Mastro

Kevin Kalinsky

Thomas Karn

Elisabetta Munzone

Federica Giugliano

Giampaolo Bianchini

Make your next move.